Skip to main content

Researches Our research spans a wide range from basic organic synthesis, drug design and development, structure elucidation of newly synthesized compound and natural products. The research focuses on the following strategic Research Themes: Design and synthesis of new chemical entities. Computer aided drug design studies. Structure-Activity relationship studies. Combinatorial chemistry. Prod rugs developments. Analytical methods for bioavailability and metabolic studies. Research within these Themes is carried out in multidisciplinary groupings focused on the discovery of novel techniques and/or enhancement of the already existing ones. At the department of Medicinal Pharmacy, We have major national and international collaborative research projects and a significant output of research publications in high-ranking journals. Our academic collaborators include many Universities in USA, Canada, Japan, and a number of major European universities.

# Title Research Year
281 Synthesis of 5-Phenyl-1-(3-pyridyl)-1H-1,2,4-triazole-3-carboxylic Acid Derivatives of Potential Anti-inflammatory Activity. 2006
282 The Utility and Synthetic Uses of Mannich Reaction: An efficient Route for Synthesis of Thiadiazino-[1,3,5][3,2-a]Benzimidazoles. 2006
283 Allophenylnorstatine-containing HIV-1 protease inhibitors: design,synthesis and structure activity relationships for selected P2 ligands.
2005
284 Allophenylnorstatine-containing HIV-1 protease inhibitors: design,synthesis and structure activity relationships for selected P2 ligands.
2005
285 Allophenylnorstatine-containing HIV-1 protease inhibitors: design,synthesis and structure activity relationships for selected P2 ligands.
2005
286 Allophenylnorstatine-containing HIV-1 protease inhibitors: design,synthesis and structure activity relationships for selected P2 ligands.
2005
287 Antisense Oligonucleotides: The State of the Art ‘A Review Article’. 2005
288 Chemometrics assisted spectrophotometric method for simultaneous determination of certain fluoroquinolones and their decarboxylated degradants
2005
289 Enhanced delivery of c-secretase inhibitor DAPT into the brain via an ascorbic acid mediated strategy 2005
290 Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents. 2005